regional neuroblastoma
Showing 1 - 25 of 3,594
Neuroblastoma Trial in Canada, United States (Sorafenib, Cyclophosphamide, Topotecan)
Active, not recruiting
- Neuroblastoma
- Sorafenib
- +2 more
-
Los Angeles, California
- +11 more
Jan 30, 2023
Neuroblastoma Trial in United States (131I-MIBG, Dinutuximab, Vorinostat)
Recruiting
- Neuroblastoma
- 131I-MIBG
- +4 more
-
Los Angeles, California
- +11 more
Jan 30, 2023
Neuroblastoma Precision Trial
Active, not recruiting
- Neuroblastoma
- Gene panel sequencing of tumor specimens
-
Los Angeles, California
- +10 more
Feb 16, 2022
Disseminated Neuroblastoma, Ganglioneuroblastoma, Localized Resectable Neuroblastoma Trial in United States (drug, radiation,
Active, not recruiting
- Disseminated Neuroblastoma
- +5 more
- cyclophosphamide
- +18 more
-
Birmingham, Alabama
- +22 more
Mar 3, 2022
Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Australia, Canada,
Completed
- Localized Resectable Neuroblastoma
- +4 more
- Clinical Observation
- +5 more
-
Birmingham, Alabama
- +103 more
Jan 4, 2023
Patients With Previously Diagnosed High-Risk Neuroblastoma
Active, not recruiting
- Recurrent Neuroblastoma
- +5 more
- Cytology Specimen Collection Procedure
- +2 more
-
Birmingham, Alabama
- +97 more
Oct 28, 2022
Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Recurrent Neuroblastoma Trial in Worldwide
Active, not recruiting
- Localized Resectable Neuroblastoma
- +5 more
- Aldesleukin
- +6 more
-
Birmingham, Alabama
- +196 more
Dec 30, 2022
Disseminated Neuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (drug,
Active, not recruiting
- Disseminated Neuroblastoma
- +4 more
- cyclophosphamide
- +14 more
-
Birmingham, Alabama
- +120 more
Mar 3, 2022
High Risk Neuroblastoma, Recurrent Neuroblastoma, Refractory Neuroblastoma Trial in Worldwide (Dinutuximab, Eflornithine
Recruiting
- High Risk Neuroblastoma
- +2 more
- Dinutuximab
- +4 more
-
Birmingham, Alabama
- +141 more
Dec 28, 2022
Ganglioneuroblastoma, Nodular, Neuroblastoma Trial in Worldwide (Dinutuximab, Irinotecan, Isotretinoin)
Active, not recruiting
- Ganglioneuroblastoma, Nodular
- Neuroblastoma
- Dinutuximab
- +4 more
-
Mesa, Arizona
- +77 more
Aug 17, 2022
Neuroblastoma, Rhabdomyosarcoma, Ewing Sarcoma Family of Tumors Trial in France (Sampling on blood, bone marrow and
Recruiting
- Neuroblastoma
- +5 more
- Sampling on blood, bone marrow and cerebrospinal fluid
-
Amiens, France
- +29 more
Feb 23, 2022
Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma Trial in Worldwide (Carboplatin,
Recruiting
- Ganglioneuroblastoma
- +3 more
- Carboplatin
- +6 more
-
Birmingham, Alabama
- +219 more
Aug 17, 2022
Tumor Tissue Samples From Newly Diagnosed Neuroblastoma or
Recruiting
- Ganglioneuroblastoma
- +5 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +258 more
Mar 23, 2022
Ganglioneuroblastoma, Neuroblastoma Trial in Canada, Puerto Rico, United States (procedure, drug, biological, radiation)
Recruiting
- Ganglioneuroblastoma
- Neuroblastoma
- Autologous Hematopoietic Stem Cell Transplantation
- +18 more
-
Birmingham, Alabama
- +158 more
Sep 14, 2022
Colorectal Cancer, Metastatic Colorectal Cancer Trial in United States (Onvansertib, FOLFIRI, Bevacizumab)
Recruiting
- Colorectal Cancer
- Metastatic Colorectal Cancer
- Onvansertib
- +2 more
-
Birmingham, Alabama
- +38 more
Jan 25, 2023
Ch14.18 in Younger Patients With High-Risk Neuroblastoma
Completed
- Localized Resectable Neuroblastoma
- +6 more
- Cytology Specimen Collection Procedure
- Pharmacological Study
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Sep 30, 2019
Neuroblastoma Trial in New York (beta-glucan, mAb 3F8, immunohistochemistry staining method)
Completed
- Neuroblastoma
- beta-glucan
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 4, 2022
Brain Tumor, CNS Tumor, Childhood Germ Cell Tumor Trial in Australia, Canada, United States (sodium thiosulfate, examination)
Completed
- Brain Tumor
- +8 more
- sodium thiosulfate
- examination
-
Birmingham, Alabama
- +75 more
Jul 1, 2021
Neuroblastoma Trial in New York (anti-GD2 murine IgG3 mAb 3F8)
Completed
- Neuroblastoma
- anti-GD2 murine IgG3 monoclonal antibody 3F8
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Apr 21, 2022
Neuroblastoma Trial in Worldwide (Data-collection)
Recruiting
- Neuroblastoma
- Data-collection
-
Wien,, Vienna, Austria
- +13 more
Oct 28, 2022
Olfactory Neuroblastoma, Esthesioneuroblastoma, Tumor of the Nasal Cavity Trial run by the NCI (Bintrafusp alfa / M7824)
Recruiting
- Olfactory Neuroblastoma
- +2 more
- Bintrafusp alfa / M7824
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 6, 2022
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +68 more
Aug 4, 2022